Skip to content
Toggle Navigation
Platform
Pipeline
Our Team
Our Story
Partnerships
News
Careers
Contact
Back to News
Categories:
Publication
|
Published On:
February 21
,
2021
|
Written by
Brandon Tilley
|
Biolojic’s anti IL2 antibody covered in Nature’s review of current IL2 therapies in development
Back to News
More News
A novel therapeutically active anti-TNFR2 agonistic antibody promotes Treg proliferation and induction of Treg functional markers
Read More
A Novel Computationally Designed Multibody Targeting IL-13/TSLP for Precision Therapy in TH2-Mediated Diseases
Read More
BUSINESS AND MEDIA INQUIRIES
Micah Pearlman
micah@biolojic.com
Page load link
Go to Top